Investors

Press Releases

Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.

Select Year
Search …

Found 351 Results

Palatin Technologies to Present at the 36th Annual Canaccord Genuity Growth Conference

August 8, 2016

Palatin Technologies Announces Completion of All Patient Visits In Phase 3 Clinical Trials of Bremelanotide for Hypoactive Sexual Desire Disorder

August 4, 2016

Palatin Technologies Announces Closing of $9.2 Million Financing

August 4, 2016

Palatin Technologies Announces $9.25 Million Financing

August 1, 2016

Palatin Technologies Receives Patent Strengthening Its Melanocortin Peptide Intellectual Property

June 6, 2016

Palatin Technologies Receives Patent Strengthening Its Melanocortin Peptide Intellectual Property

May 26, 2016

Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2016 Results; Teleconference and Webcast to be held on May 17, 2016

May 17, 2016

Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2016 Results

May 12, 2016

Palatin Technologies Presents Bremelanotide Alcohol Interaction Study at International Society for the Study of Women’s Sexual Health Annual Meeting

February 26, 2016

Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2016 Results; Teleconference and Webcast to be held on February 16, 2016

February 16, 2016

Newer

Page 23 of 36

Older